Previous Article | Next Article 
Journal of Virology, June 2008, p. 6039-6044, Vol. 82, No. 12
0022-538X/08/$08.00+0 doi:10.1128/JVI.02753-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Small Intestine CD4+ T Cells Are Profoundly Depleted during Acute Simian-Human Immunodeficiency Virus Infection, Regardless of Viral Pathogenicity
Yoshinori Fukazawa,1,
Ariko Miyake,1,2,
Kentaro Ibuki,1
Katsuhisa Inaba,1
Naoki Saito,1
Makiko Motohara,1
Reii Horiuchi,1
Ai Himeno,1
Kenta Matsuda,1
Megumi Matsuyama,1
Hidemi Takahashi,3
Masanori Hayami,1
Tatsuhiko Igarashi,1 and
Tomoyuki Miura1*
Laboratory of Primate Model, Experimental Research Center for Infectious Diseases, Institute for Virus Research, Kyoto University, 53 Shogoinkawaramachi, Sakyo-ku, Kyoto 606-8507, Japan,1
Laboratory of Tumor Cell Biology, Department of Medical Genome Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo 162-8640, Japan,2
Department of Microbiology and Immunology, Nippon Medical School, Tokyo 113-8602, Japan3
Received 27 December 2007/
Accepted 27 March 2008

ABSTRACT
To analyze the relationship between acute virus-induced injury
and the subsequent disease phenotype, we compared the virus
replication and CD4
+ T-cell profiles for monkeys infected with
isogenic highly pathogenic (KS661) and moderately pathogenic
(#64) simian-human immunodeficiency viruses (SHIVs). Intrarectal
infusion of SHIV-KS661 resulted in rapid, systemic, and massive
virus replication, while SHIV-#64 replicated more slowly and
reached lower titers. Whereas KS661 systemically depleted CD4
+ T cells, #64 caused significant CD4
+ T-cell depletion only in
the small intestine. We conclude that SHIV, regardless of pathogenicity,
can cause injury to the small intestine and leads to CD4
+ T-cell
depletion in infected animals during acute infection.

TEXT
The highly pathogenic simian-human immunodeficiency virus (SHIV)
SHIV-C2/1-KS661 (KS661), which was derived from SHIV-89.6 (
23),
replicates to high titers and causes the irreversible depletion
of the circulating CD4
+ T cells during the acute phase of intravenous
infection, followed by AIDS-like disease within 1 year (
23).
We previously reported that KS661 massively replicates and depletes
CD4
+ T cells in both peripheral and mucosal lymphoid tissues
during the initial 4 weeks postinfection (
16). On the other
hand, the isogenic SHIV-#64 (#64), which was derived from SHIV-89.6P,
is moderately pathogenic. The genomic sequences of the two SHIVs
differ by only 0.16%, resulting in a total of six amino acid
changes in the products of the
pol,
env-gp41, and
rev genes.
The intravenous inoculation of rhesus macaques with #64 induces
plasma viral burdens comparable to those induced by KS661 during
the acute phase of infection and causes a transient reduction
of the circulating CD4
+ T lymphocytes (
10). After the acute
phase, the viral loads decline to undetectable levels and the
populations of CD4
+ T cells recover to preinfection levels.
To clarify the relationship between acute viral replication kinetics and subsequent clinical courses for these isogenic SHIVs with distinct pathogenicities, we examined proviral DNA, infectious-virus-producing cells (IVPCs), and CD4+ T-cell depletion in peripheral and mucosal lymphoid tissues of 17 infected (Table 1) and 7 uninfected adult rhesus macaques (Macaca mulatta). Both Chinese and Indian rhesus monkeys were randomly assigned to these groups. The monkeys were used in accordance with the institutional regulations approved by the Committee for Experimental Use of Nonhuman Primates of the Institute for Virus Research, Kyoto University, Kyoto, Japan. The animals were inoculated via intrarectal infusion as described previously (17). Following serial euthanasia, tissues were collected and analyzed up to 27 days postinfection (dpi) as described previously (16, 17).
Gross virus replication was assessed by measuring plasma viral
loads by reverse transcriptase PCR (
16). By 6 dpi, plasma viral
RNA levels became detectable in all the KS661-infected macaques
(Fig.
1A) and three of seven #64-infected macaques (animals
MM372, MM391, and MM374) (Fig.
1B). Although the plasma viral
loads of the two groups at 13 dpi, when the virus loads reached
their initial peaks, were not significantly different (
P = 0.1673),
the average load (± the standard deviation) in KS661-infected
monkeys (9.3
x 10
8 ± 15.9
x 10
8 copies/ml) was about
10 times higher than that in #64-infected monkeys (6.3
x 10
7 ± 11.6
x 10
7 copies/ml). These results suggest that KS661
spread faster and reached a somewhat higher titer than did #64
when the viruses were inoculated intrarectally.
Levels of peripheral blood CD4
+ T lymphocytes in all the KS661-infected
monkeys decreased substantially within 4 weeks (Fig.
1C). On
the other hand, the reductions in the levels of CD4
+ T cells
varied among the #64-infected monkeys (Fig.
1D). For example,
MM378 did not exhibit any appreciable changes, even though the
plasma viral RNA load in this monkey reached 2.6
x 10
7 copies/ml
by 21 dpi (Fig.
1 B and D). These data suggest that the decline
in circulating CD4
+ T cells in KS661-infected animals was more
severe and more reproducible than that in the #64-infected monkeys.
Another highly pathogenic SHIV, SHIV-DH12R, is known to cause systemic and synchronous replication events in animals following intravenous inoculation (6). To reveal the spread of virus in monkeys following intrarectal infection, we measured proviral DNA loads in a variety of tissues as described previously (16). KS661 proviral DNA was detected not only in samples from the rectums, the site of virus inoculation, but also in peripheral blood mononuclear cells and some lymph nodes (LN) at 6 dpi (Fig. 2A), suggesting that the virus was already spreading systemically. At 13 dpi, when the viral RNA loads in peripheral blood increased to the highest titers, proviral DNA levels in all of the tissues examined also increased, with levels in most monkeys exceeding 104 copies/µg of DNA. The levels of proviral DNA in all the tissues declined remarkably by 27 dpi. In contrast, #64 proviral DNA was detected only in the rectum of one (MM390) of the two monkeys examined at 6 dpi (Fig. 2A). At 13 dpi, the amount of proviral DNA in each tissue sample from #64-infected monkeys (<104 copies/µg of DNA) was considerably smaller than that in each sample from the KS661-infected monkeys. However, unlike the KS661 proviral DNA levels, the #64 proviral DNA levels in most tissues were maintained up to 27 dpi. These results suggest that #64 spread more slowly than KS661 and that the amounts of proviral DNA in a variety of tissues from the #64-infected animals were smaller than those in the tissues from KS661-infected animals around the initial peak of plasma viremia.
Because the amount of proviral DNA measured by PCR may include
nonreplicating remnants of the viral genome, we also measured
the number of IVPCs in each tissue sample by a plaque assay
as described previously (
9,
15). Briefly, cells prepared from
infected animals were mixed with human T-lymphoid M8166 indicator
cells, resuspended in culture medium containing 0.4% agarose,
and plated into petri dishes. The plaques that formed in the
cell layer were counted after 10 days of cultivation, and the
number of IVPCs was calculated. For the KS661-infected monkeys,
high numbers of IVPCs in all the tissue samples examined at
13 dpi were detected (Fig.
2B). Among these samples, the thymus
and mesenteric LN samples harbored especially high numbers of
IVPCs (more than 500/10
6 cells) at 13 dpi. The numbers of IVPCs
declined remarkably from 13 to 27 dpi. We concluded that KS661
replicated systemically and synchronously in a variety of tissues,
including the intestinal tract, at 13 dpi. In contrast, #64
production patterns in different tissues were not synchronous.
Among #64-infected monkeys at 6 dpi, virus production was most
active in the jejunum lamina propria lymphocytes (LPL) of MM390
(166 IVPCs/10
6 cells). At 13 dpi, interestingly, mesenteric
LN became the center of virus production in two of the three
monkeys examined (MM372 and MM373; 259 and 160 IVPCs/10
6 cells).
In the other monkey (MM391), the jejunum had the highest number
of IVPCs, followed by the mesenteric LN. These results suggested
that the virus that replicated in the jejunum spread directly
into the mesenteric LN via the flow of lymphatic fluid. At 27
dpi, the thymus tissues of both monkeys examined (MM374 and
MM378) exhibited the highest numbers of IVPCs. In summary, the
systemic dissemination of #64 was slower than that of KS661,
and it was particularly delayed in the thymus during the acute
phase.
Systemic CD4+ cell depletion is the signature of disease induced by highly pathogenic SHIVs (7, 8, 22). We therefore compared the frequencies of CD4+ cells in tissues from the animals infected with KS661 and #64, in addition to those of the circulating CD4+ T lymphocytes. As representatives of the major virus-producing organs, the thymus, the mesenteric LN, and the jejunum were selected for examination. CD4 cell numbers were measured by immunohistochemistry analyses as described previously (18). Uninfected thymus tissue contained abundant CD4+ cells that were stained brown (Fig. 3A, panel a), while the tissue collected from the KS661-infected animal at 27 dpi harbored few such cells (Fig. 3A, panel b). #64 caused virtually no CD4+ cell depletion in the thymus at 27 dpi (Fig. 3A, panel c). In the mesenteric LN of uninfected monkeys, CD4+ cells were found in the paracortical region (Fig. 3A, panel d). KS661 depleted CD4+ cells in this area (Fig. 3A, panel e). Unlike KS661, #64 did not reduce the level of CD4+ cells (Fig. 3A, panel f). The jejunum samples from uninfected animals contained CD4+ cells in the lamina propria and follicles of gut-associated lymphatic tissues (Fig. 3 A, panel g). KS661 depleted CD4+ cells in these tissues, too (Fig. 3A, panel h). Interestingly, #64 caused CD4+ cell depletion in the small intestine comparable to that caused by KS661 (Fig. 3A, panel i). To confirm the observed cell reduction in the jejunum samples, we randomly selected a total of 40 fields on the tissue sections from each animal for viewing at a total magnification of x400, counted CD4+ cells, and averaged the numbers (Fig. 3B). The CD4+ cell densities in the jejunum samples from the #64-infected monkeys were significantly lower than those in the samples from uninfected animals (P < 0.001). This gut-specific CD4+ cell depletion caused by #64 prompted us to analyze the frequencies of CD4+ T cells (including CD4 and CD8 doubly positive cells) in a variety of tissues by flow cytometry (Fig. 3C). KS661 caused systemic CD4+ T-lymphocyte depletion by 27 dpi (Fig. 3C). In agreement with the immunohistochemistry results, #64 significantly depleted CD4+ T cells only in the jejunum intraepithelial lymphocytes and LPL (P = 0.01 and 0.003, respectively) (Fig. 3C) by 27 dpi, although we examined only two #64-infected monkeys at 27 dpi. In conclusion, the CD4+ T-cell depletion patterns caused by KS661 and #64 were distinct, and the small intestine was the only site in which CD4+ T cells were significantly depleted by the moderately pathogenic #64.
Taken together, our results show that #64 disseminated more
slowly and replicated less than KS661 in systemic lymphoid tissues,
as well as in peripheral blood, during the acute phase of infection.
We believe that because of its low rate and low levels of replication,
#64 could not cause irreversible injury before the host mounted
an immune reaction. As a result, CD4
+ T cells were not completely
depleted in all the tissues examined, except in the small intestine.
These results suggest that the small intestine is the tissue
most sensitive to virus-induced CD4
+ T-cell depletion during
the acute phase of infection. Recent reports revealed that severe
acute depletions of mucosal CD4
+ T cells have been observed
in simian immunodeficiency virus-infected monkeys (
11,
12,
24,
25) and human immunodeficiency virus-infected humans (
2,
5,
13). The acute depletion of mucosal CD4
+ T cells and the disease
outcome are correlated (
1,
3,
21,
26). However, a decrease of
mucosal CD4
+ T cells has also been observed in the early phases
of natural host infections, such as SIVagm infection in African
green monkeys and SIVsmm infection in sooty mangabeys, which
typically do not progress to AIDS (
4,
14,
19). In addition,
the levels of apoptosis and immune activation and the degrees
of CD4
+ T-cell restoration differ between progressors and nonprogressors
in simian immunodeficiency virus models (
4,
14,
19). Taken together,
these results raise the possibility that the severe acute depletion
of mucosal CD4
+ T cells is not sufficient to induce AIDS. The
restoration of CD4
+ T cells and normal immune function after
the severe acute depletion may define the eventual disease outcome
(
20). The abilities of KS661- and #64-infected monkeys to restore
the immune system may be different, because KS661, but not #64,
impairs thymic T-cell differentiation (
18). Currently, we are
focusing on the restoration of CD4
+ T cells and the functional
aspect of the immune cells in the small intestines of animals
infected with KS661 and #64 to further clarify the determinant(s)
of the disease outcome.

ACKNOWLEDGMENTS
We are grateful to James Raymond for English editing of the
manuscript and to Takahito Kazama for technical support.
This work was supported, in part, by Research on Human Immunodeficiency Virus/AIDS in Health and Labor Sciences research grants from the Ministry of Health, Labor and Welfare, Japan, a grant-in-aid for scientific research from the Ministry of Education and Science, Japan, a research grant for health sciences focusing on drug innovation for AIDS from the Japan Health Sciences Foundation, and a grant from the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan.

FOOTNOTES
* Corresponding author. Mailing address: Laboratory of Primate Model, Experimental Research Center for Infectious Diseases, Institute for Virus Research, Kyoto University, 53 Shogoinkawaramachi, Sakyo-ku, Kyoto 606-8507, Japan. Phone: 81-75-751-3984. Fax: 81-75-761-9335. E-mail:
tmiura{at}virus.kyoto-u.ac.jp 
Published ahead of print on 9 April 2007. 
These authors contributed equally to this work. 

REFERENCES
1 - Brenchley, J. M., D. A. Price, and D. C. Douek. 2006. HIV disease: fallout from a mucosal catastrophe? Nat. Immunol. 7:235-239.[CrossRef][Medline]
2 - Brenchley, J. M., T. W. Schacker, L. E. Ruff, D. A. Price, J. H. Taylor, G. J. Beilman, P. L. Nguyen, A. Khoruts, M. Larson, A. T. Haase, and D. C. Douek. 2004. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200:749-759.[Abstract/Free Full Text]
3 - Chase, A., Y. Zhou, and R. F. Siliciano. 2006. HIV-1-induced depletion of CD4+ T cells in the gut: mechanism and therapeutic implications. Trends Pharmacol. Sci. 27:4-7.[CrossRef][Medline]
4 - Gordon, S. N., N. R. Klatt, S. E. Bosinger, J. M. Brenchley, J. M. Milush, J. C. Engram, R. M. Dunham, M. Paiardini, S. Klucking, A. Danesh, E. A. Strobert, C. Apetrei, I. V. Pandrea, D. Kelvin, D. C. Douek, S. I. Staprans, D. L. Sodora, and G. Silvestri. 2007. Severe depletion of mucosal CD4+ T cells in AIDS-free simian immunodeficiency virus-infected sooty mangabeys. J. Immunol. 179:3026-3034.[Abstract/Free Full Text]
5 - Guadalupe, M., E. Reay, S. Sankaran, T. Prindiville, J. Flamm, A. McNeil, and S. Dandekar. 2003. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 77:11708-11717.[Abstract/Free Full Text]
6 - Igarashi, T., C. R. Brown, R. A. Byrum, Y. Nishimura, Y. Endo, R. J. Plishka, C. Buckler, A. Buckler-White, G. Miller, V. M. Hirsch, and M. A. Martin. 2002. Rapid and irreversible CD4+ T-cell depletion induced by the highly pathogenic simian/human immunodeficiency virus SHIV(DH12R) is systemic and synchronous. J. Virol. 76:379-391.[Abstract/Free Full Text]
7 - Igarashi, T., Y. Endo, G. Englund, R. Sadjadpour, T. Matano, C. Buckler, A. Buckler-White, R. Plishka, T. Theodore, R. Shibata, and M. A. Martin. 1999. Emergence of a highly pathogenic simian/human immunodeficiency virus in a rhesus macaque treated with anti-CD8 mAb during a primary infection with a nonpathogenic virus. Proc. Natl. Acad. Sci. USA 96:14049-14054.[Abstract/Free Full Text]
8 - Joag, S. V., Z. Li, L. Foresman, E. B. Stephens, L.-J. Zhao, I. Adany, D. M. Pinson, H. M. McClure, and O. Narayan. 1996. Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques. J. Virol. 70:3189-3197.[Abstract]
9 - Kato, S., Y. Hiraishi, N. Nishimura, T. Sugita, M. Tomihama, and T. Takano. 1998. A plaque hybridization assay for quantifying and cloning infectious human immunodeficiency virus type 1 virions. J. Virol. Methods 72:1-7.[CrossRef][Medline]
10 - Kozyrev, I. L., K. Ibuki, T. Shimada, T. Kuwata, T. Takemura, M. Hayami, and T. Miura. 2001. Characterization of less pathogenic infectious molecular clones derived from acute-pathogenic SHIV-89.6p stock virus. Virology 282:6-13.[CrossRef][Medline]
11 - Li, Q., L. Duan, J. D. Estes, Z. M. Ma, T. Rourke, Y. Wang, C. Reilly, J. Carlis, C. J. Miller, and A. T. Haase. 2005. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 434:1148-1152.[Medline]
12 - Mattapallil, J. J., D. C. Douek, B. Hill, Y. Nishimura, M. Martin, and M. Roederer. 2005. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434:1093-1097.[CrossRef][Medline]
13 - Mehandru, S., M. A. Poles, K. Tenner-Racz, A. Horowitz, A. Hurley, C. Hogan, D. Boden, P. Racz, and M. Markowitz. 2004. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 200:761-770.[Abstract/Free Full Text]
14 - Milush, J. M., J. D. Reeves, S. N. Gordon, D. Zhou, A. Muthukumar, D. A. Kosub, E. Chacko, L. D. Giavedoni, C. C. Ibegbu, K. S. Cole, J. L. Miamidian, M. Paiardini, A. P. Barry, S. I. Staprans, G. Silvestri, and D. L. Sodora. 2007. Virally induced CD4+ T cell depletion is not sufficient to induce AIDS in a natural host. J. Immunol. 179:3047-3056.[Abstract/Free Full Text]
15 - Miyake, A., Y. Enose, S. Ohkura, H. Suzuki, T. Kuwata, T. Shimada, S. Kato, O. Narayan, and M. Hayami. 2004. The quantity and diversity of infectious viruses in various tissues of SHIV-infected monkeys at the early and AIDS stages. Arch. Virol. 149:943-955.[CrossRef][Medline]
16 - Miyake, A., K. Ibuki, Y. Enose, H. Suzuki, R. Horiuchi, M. Motohara, N. Saito, T. Nakasone, M. Honda, T. Watanabe, T. Miura, and M. Hayami. 2006. Rapid dissemination of a pathogenic simian/human immunodeficiency virus to systemic organs and active replication in lymphoid tissues following intrarectal infection. J. Gen. Virol. 87:1311-1320.[Abstract/Free Full Text]
17 - Miyake, A., K. Ibuki, H. Suzuki, R. Horiuchi, N. Saito, M. Motohara, M. Hayami, and T. Miura. 2005. Early virological events in various tissues of newborn monkeys after intrarectal infection with pathogenic simian human immunodeficiency virus. J. Med. Primatol. 34:294-302.[CrossRef][Medline]
18 - Motohara, M., K. Ibuki, A. Miyake, Y. Fukazawa, K. Inaba, H. Suzuki, K. Masuda, N. Minato, H. Kawamoto, T. Nakasone, M. Honda, M. Hayami, and T. Miura. 2006. Impaired T-cell differentiation in the thymus at the early stages of acute pathogenic chimeric simian-human immunodeficiency virus (SHIV) infection in contrast to less pathogenic SHIV infection. Microbes Infect. 8:1539-1549.[CrossRef][Medline]
19 - Pandrea, I. V., R. Gautam, R. M. Ribeiro, J. M. Brenchley, I. F. Butler, M. Pattison, T. Rasmussen, P. A. Marx, G. Silvestri, A. A. Lackner, A. S. Perelson, D. C. Douek, R. S. Veazey, and C. Apetrei. 2007. Acute loss of intestinal CD4+ T cells is not predictive of simian immunodeficiency virus virulence. J. Immunol. 179:3035-3046.[Abstract/Free Full Text]
20 - Picker, L. J. 2006. Immunopathogenesis of AIDS virus infection. Curr. Opin. Immunol. 18:399-405.[CrossRef][Medline]
21 - Picker, L. J., and D. I. Watkins. 2005. HIV pathogenesis: the first cut is the deepest. Nat. Immunol. 6:430-432.[CrossRef][Medline]
22 - Reimann, K. A., J. T. Li, R. Veazey, M. Halloran, I. W. Park, G. B. Karlsson, J. Sodroski, and N. L. Letvin. 1996. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. J. Virol. 70:6922-6928.[Abstract/Free Full Text]
23 - Shinohara, K., K. Sakai, S. Ando, Y. Ami, N. Yoshino, E. Takahashi, K. Someya, Y. Suzaki, T. Nakasone, Y. Sasaki, M. Kaizu, Y. Lu, and M. Honda. 1999. A highly pathogenic simian/human immunodeficiency virus with genetic changes in cynomolgus monkey. J. Gen. Virol. 80:1231-1240.[Abstract]
24 - Smit-McBride, Z., J. J. Mattapallil, M. McChesney, D. Ferrick, and S. Dandekar. 1998. Gastrointestinal T lymphocytes retain high potential for cytokine responses but have severe CD4+ T-cell depletion at all stages of simian immunodeficiency virus infection compared to peripheral lymphocytes. J. Virol. 72:6646-6656.[Abstract/Free Full Text]
25 - Veazey, R. S., M. DeMaria, L. V. Chalifoux, D. E. Shvetz, D. R. Pauley, H. L. Knight, M. Rosenzweig, R. P. Johnson, R. C. Desrosiers, and A. A. Lackner. 1998. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280:427-431.[Abstract/Free Full Text]
26 - Veazey, R. S., and A. A. Lackner. 2004. Getting to the guts of HIV pathogenesis. J. Exp. Med. 200:697-700.[Abstract/Free Full Text]
Journal of Virology, June 2008, p. 6039-6044, Vol. 82, No. 12
0022-538X/08/$08.00+0 doi:10.1128/JVI.02753-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.